Phlox Therapeutics focuses on developing gene therapies aimed at alleviating and curing various forms of cardiomyopathy and other heart diseases. The company employs innovative technologies, including RNA-based therapeutics and other cardiac solutions, to provide patients with lasting benefits. By targeting the underlying genetic mutations responsible for these conditions, Phlox Therapeutics aims to improve patient outcomes and offer effective treatment options for genetic heart diseases.
Flavour
Venture Round in 2024
Flavor enables playful learning, change and activation through Applied Gaming and Storytelling.
Aurea Imaging
Series A in 2024
Aurea Imaging specializes in software engineering and geographic information systems, focusing on agricultural services and data analysis. The company develops unmanned aerial vehicle technology that leverages geographic information systems and earth observation techniques. This technology conducts spectral analysis to classify geological features and lithology from hyperspectral data collected via sensors on satellites and aircraft. By integrating this analysis with additional information, Aurea Imaging enhances geological maps and identifies potential mineral concentrations on the surface. Their commitment to accurate and consistent data collection, processing, and analysis ensures that their products meet the specific needs of clients, enabling effective investigation of environmental changes.
NEFFA
Seed Round in 2024
NEFFA is a company focused on revolutionizing the fashion industry by addressing its environmental impact through innovative production methods. The fashion sector is known for its significant contribution to global CO2 emissions and water contamination. NEFFA employs a sustainable approach by utilizing a digital design interface that allows for 3D design and the application of parametric textures. Their production method creates affordable, recyclable 3D molds without the need for high heat or pressure, enabling efficient manufacturing. Currently, NEFFA specializes in using mycelium to produce MycoTEX, a sustainable textile, but their technology can also accommodate various biomaterials grown through liquid fermentation, such as algae and collagen. This seamless production process emphasizes custom-fit products and on-demand manufacturing, reducing waste and promoting eco-friendly clothing solutions.
Cordys Analytics
Seed Round in 2023
Cordys Analytics focuses on detecting heart illness via electrocardiograms (ECGs) using AI-powered algorithms. It aims to transform cardiac care by offering doctors easy access to AI diagnoses for electrocardiograms (ECGs).
Pltfrm
Venture Round in 2023
PLTFRM is an information technology platform designed to streamline collaboration between IT service providers and clients. By creating a network of specialists in various IT fields, PLTFRM helps businesses identify and select the most suitable service providers to address their specific IT challenges. The platform facilitates the formation of a customized IT ecosystem, dynamically contracting the best specialists for each aspect of a project. With features such as an easy management interface, secure communication tools, and mechanisms for quick feedback, PLTFRM aims to simplify the relationship between freelancers and clients, making it as manageable as a traditional office environment. Ultimately, PLTFRM seeks to transform the way individuals and organizations work together, promoting a seamless experience in engaging with independent contractors.
FourOneFour
Seed Round in 2023
The FourOneFour platform makes it easy and dependable to adhere to EU legislation pertaining to sustainable financing.
Neurolytics
Seed Round in 2023
Neurolytics offers a platform that enhances the recruitment process through objective behavioral analytics. By utilizing a SaaS solution, the company enables small businesses to improve candidate selection with an automated video assessment tool. This tool allows hiring teams to leverage artificial intelligence and video technology for company-specific candidate evaluations that can be conducted remotely. Through scientific research and techniques, Neurolytics aims to provide unbiased recruitment scans, helping businesses identify suitable candidates, broaden their talent pool, and minimize employee turnover.
Cleara Biotech
Seed Round in 2022
Cleara Biotech B.V., based in Utrecht, the Netherlands, focuses on developing therapeutics aimed at selectively eliminating senescent and senescent-like cancer cells. The company is particularly engaged in creating FOXO4-based anti-senescence drugs designed to counteract chemotoxicity and address therapy-resistant cancer cells. By targeting these problematic cells, Cleara Biotech seeks to advance cancer treatment and improve patient outcomes.
Sensoterra
Venture Round in 2022
Sensoterra specializes in developing wireless soil moisture sensors aimed at optimizing irrigation for growers and landscapers. With the world's freshwater supplies declining and agriculture accounting for 70% of water consumption, efficient irrigation practices are crucial. Many growers currently over-irrigate by up to 60%, leading to significant water waste, increased costs, and soil degradation. Sensoterra's sensors address these issues by providing real-time monitoring and actionable insights, allowing users to measure soil moisture accurately. This data helps optimize water usage, potentially reducing water consumption by up to 30%. The technology supports better irrigation management in both agricultural and urban settings, promoting sustainability and efficiency in water use.
Prolira BV
Venture Round in 2022
Prolira BV is a Dutch company based in Utrecht that specializes in developing medical technology for the early detection of delirium, an acute brain failure condition. Founded in 2015, Prolira has introduced DeltaScan, an EEG-based device designed to monitor brain activity and facilitate timely treatment for patients at risk of acute encephalopathy and delirium. The DeltaScan system comprises a single-use electrode patch, known as the DeltaScan Patch, and the DeltaScan Monitor, which employs a validated proprietary algorithm to analyze EEG data. This innovative approach aims to enhance patient recovery by supporting clinicians in identifying and addressing delirium, a condition that affects approximately 20 million patients annually in hospitals across Europe and the United States, leading to significant cognitive impairment and increased healthcare costs.
Prepr
Series A in 2022
Prepr is a developer of a headless content management system (CMS) that integrates a personalization engine to enhance content management and multichannel publishing. The platform is designed to help businesses create and manage exceptional customer experiences that drive engagement and conversion. By offering features such as lean customer profiles, real-time segments, and content targeting, Prepr empowers companies to maximize the impact of their content while reducing development costs and accelerating time-to-market. This all-in-one solution is particularly suited for media brands and broadcasters, enabling them to publish, optimize, and evaluate their content effectively across multiple sites.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.